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Predicts Outcome in Type A Aortic Dissection
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Markus Thalmann, MD,‡ Marek P. Ehrlich, MD,‡ Georg Endler, MD,§ Anton Laggner, MD*
Vienna, Austria
Background Acute Stanford type A aortic dissection (AAD) is associated with substantial perioperative mortality and morbidity.
Objective N-terminal pro-brain natriuretic peptide (NT-proBNP) is a prognostic biomarker of outcome in cardiovascular dis-
ease. Its predictive power in patients undergoing emergency surgery for acute type A aortic dissection is yet un-
known.
Methods We prospectively measured pre-operative NT-proBNP in 104 patients (39 female, 35%; median age 61 years)
undergoing emergency surgery for AAD during a 6-year study period. European System for Cardiac Operative
Risk Evaluation risk scores were recorded and patients were followed for 30-day mortality and major adverse
events (MAEs) as defined by the need for rethoracotomy, occurrence of postoperative heart failure, neurologic
deficit, lung failure, renal failure, or sepsis.
Results Median logistic European System for Cardiac Operative Risk Evaluation in the cohort was 12 (interquartile range
7 to 19). During the first 30 days, 23 patients (22%) died, and 53 patients (51%) experienced MAEs. Median
(interquartile range) NT-proBNP levels in survivors versus nonsurvivors were 328 pg/ml (157 to 569) versus
2,240 pg/ml (515 to 4,734; p  0.001), and in patients without versus with MAEs, 227 pg/ml (107 to 328) and
719 pg/ml (442 to 2,287; p  0.001), respectively. Adjusted odds ratios for increasing tertiles of NT-proBNP
compared with the lowest tertile were 0.98 (95% confidence interval [CI] 0.18 to 5.33; p  0.98) and 11.67
(95% CI 2.61 to 52.09; p  0.001) for 30-day mortality and 9.07 (95% CI 2.58 to 31.83; p  0.001) and 50.21
(95% CI 10.85 to 232.45; p  0.001) for MAEs, respectively, indicating a significant association between pre-
operative NT-proBNP levels and outcome.
Conclusions Pre-operative NT-proBNP predicts outcome in patients undergoing surgery of AAD. (J Am Coll Cardiol 2008;51:
1092–7) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.12.015H
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dmergency surgery of patients with acute Stanford type A
ortic dissection is associated with high morbidity and
ortality rates (1–3). Although substantial advances in
urgical techniques such as selective cerebral perfusion and
eep hypothermic circulatory arrest have helped to improve
arly and long-term outcome, in-hospital mortality rates
emain excessively high (1–3).
A variety of multifactorial risk indexes have been de-
cribed to help delineate pre-operative risk assessment of
atients undergoing cardiac surgery (4–6) and, particularly,
he European System for Cardiac Operative Risk Evalua-
ion Euro-Score (EuroSCORE) (4) is frequently used.
rom the Departments of *Emergency Medicine, †Angiology, ‡Cardiothoracic
urgery, and §Laboratory Medicine, Medical University Vienna, Vienna, Austria.u
Manuscript received April 27, 2007; revised manuscript received October 10, 2007,
ccepted December 10, 2007.owever, the ability to effectively predict post-operative
omplications and mortality in acute aortic dissection re-
ains uncertain, and no gold standard exists (7). Further-
ore, many of these assessment tools are not routinely used
n pre-operative evaluation because of complexity, inaccu-
acy when applied to individuals, unavailability of important
ariables, or time constraints (8–12).
A valuable addition to the pre-operative evaluation would
herefore be a clinical routine biomarker capable of predict-
ng patients’ perioperative and early post-operative risk.
ithin this context, N-terminal pro-brain natriuretic pep-
ide (NT-proBNP) has become a recent focus of common
nterest in the diagnosis, risk stratification, and assessment
f mortality of cardiovascular diseases (13–15).
We speculated that pre-operative NT-proBNP may pre-
ict 30-day mortality and major adverse events in patients
ndergoing emergency repair of Stanford type A aortic
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March 18, 2008:1092–7 NT-proBNP and AADissection. Therefore, we investigated the association be-
ween NT-proBNP measured upon arrival of the patient in
he emergency department and peri- and post-operative
utcome within 30 days.
ethods
esign. The study was designed as a prospective cohort
tudy, including consecutive patients undergoing emergency
urgical repair of nontraumatic Stanford type A aortic
issection during a 6-year study period (from January 2000
o December 2006). Acute aortic dissection was diagnosed
t the Department of Emergency Medicine at our institu-
ion and classified according to the guidelines published by
he European Society of Cardiology (7). All study related
rocedures were in accordance with the ethical standards of
he responsible committee of the Vienna Medical School.
atient data. Cardiovascular risk factors and comorbidi-
ies, as the time point of onset of symptoms, were assessed
n admission. Pre-operatively, the additive and the logistic
uroSCORE were applied to estimate the individual pa-
ient’s outcome (for details, refer to Table 1). In brief,
uroSCORE identifies a number of risk factors that help to
redict mortality from cardiac surgery. The predicted mor-
ality (in %) is calculated by adding the weights assigned to
ach pre-operative risk factor. EuroSCORE has now been
xtensively tested and found to be valid worldwide (4–6).
dditionally, C-reactive protein and total leukocyte count,
s established surrogate markers of adverse outcome, were
btained at the time of hospital admission.
nd points. As the primary end point, all-cause 30-day
uroSCORE Logistic Regression Model
Table 1 EuroSCORE Logistic Regression Model
Variables (X1) -Coefficient
Age (continuous) 0.0666354
Female 0.3304052
Serum creatinine 200 mol/l 0.6521653
Extracardiac arteriopathy 0.6558917
Pulmonary disease 0.4931341
Neurological dysfunction 0.841626
Previous cardiac surgery 1.002625
Recent myocardial infarct 0.5460218
Left ventricular ejection fraction 30%–50% 0.4191643
Left ventricular ejection fraction 30% 1.094443
Systolic pulmonary pressure 60 mm Hg 0.7676924
Active endocarditis 1.101265
Unstable angina 0.5677075
Emergency operation 0.7127953
Critical pre-operative state 0.9058132
Ventricular septal rupture 1.462009
Other than isolated coronary surgery 0.5420364
Thoracic aortic surgery 1.159787
Constant o 4.789594
or a given patient, the logistic EuroSCORE, which is the predicted mortality according to the
ogistic regression equation, is achieved with the following formula: predicted mortality 
(o  1X1) / 1  e(o  1X1).
EuroSCORE  European System for Cardiac Operative Risk Evaluation.ortality was defined. The secondary objective was the tccurrence of major adverse
vents (MAEs) within the 30-
ay post-operative phase, as is
lassified according to criteria of
he critical care society and to the
uidelines of the Society of Tho-
acic Surgeons: acute respiratory
istress syndrome; acute heart
ailure; diffuse or focal neurologic
schemic damage, such as persis-
ent paraparesis or paraplegia due
o impairment of blood supply to
he spinal cord or signs of central
eurological damage after cere-
ral hypoperfusion; and septicemia. Acute renal failure was
efined as an increase in serum creatinine 44 mmol/l (0.5
g/dl) over the baseline value (serum creatinine on admis-
ion) or the need for renal replacement therapy until day 30.
ethoracotomy was defined as the need of surgical reinter-
ention for bleeding complications. When patients fulfilled
t least one criterion, they were classified as suffering from
ost-operative MAEs.
T-proBNP measurements. Arterial blood samples were
ollected pre-operatively into tubes containing potassium
thylene diamine tetraacetic acid. After centrifugation at
,000 g, the supernatants were frozen at80°C until use for
ooled analysis. Pre-operative NT-proBNP was measured
y chemiluminescence (Elecsys proBNP, Roche Diagnos-
ics, Mannheim, Germany) according to the manufacturer’s
ecommendations. The test uses 2 polyclonal antibodies,
hich bind to the NT-proBNP peptide and form a stable
andwich complex. The sensitivity of the test is 5 pg/ml.
ntraassay and interassay coefficients of variance at 175
g/ml are 2.7% and 3.2%, respectively, without cross reac-
ivities with other hormones.
tatistical methods. Continuous data are presented as the
edian and interquartile range (range from the 25th to the
5th percentile). Discrete data are given as counts and
ercentages. Univariate comparisons of continuous data
ere performed with Mann-Whitney U tests. Groups of
ategorical data were compared with the Fisher exact tests.
pearman correlation was applied to test for correlation
etween admission levels and time of onset of symptoms.
evels of NT-proBNP were grouped in tertiles to achieve
linically meaningful effect sizes by multivariable analysis; a
ultivariate logistic regression model was applied to assess
he independent predictive value of NT-proBNP for the
rimary and secondary study end points and to adjust for
ossible confounding factors. We adjusted the logistic
egression model for the EuroSCORE and time interval of
nset of specific symptoms to account for the potentially
onfounding effect of patients’ baseline morbidity. Results
f the logistic regression model are given as the odds ratio
OR) and the 95% confidence interval (CI). Regression
iagnostics and overall model-fit were performed according
Abbreviations
and Acronyms
CI  confidence interval
EuroSCORE  European
System for Cardiac
Operative Risk Evaluation
IQR  interquartile range
MAE  major adverse
event
NT-proBNP  N-terminal
pro-brain natriuretic peptide
OR  odds ratioo standard procedures. A 2-sided p  0.05 was considered
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NT-proBNP and AAD March 18, 2008:1092–7tatistically significant. Calculations were performed with
PSS for Windows (version 12.0, Microsoft, Seattle,
ashington).
esults
atient data. During a 6-year period, we included 104 of
18 consecutive patients with acute aortic dissection in the
resent study (39 female, 35%; median age 61 years,
nterquartile range [IQR] 51 to 67). Fourteen patients had
o be excluded because of missing data. Demographic data
nd clinical characteristics of these patients were not signif-
cantly different to patients included in the study (data not
hown).
The median pre-operative NT-proBNP level was 413
g/ml (IQR 182 to 947). We found a significant correlation
etween admission levels and time of onset of symptoms
median 6.5 h, IQR 4 to 19.5; r 0.31, p 0.001) Detailed
emographic data of the study cohort is provided in Table 2.
utcome after emergency surgery. A total of 23 deaths
22%) occurred during the first 30 days. Major adverse
vents during postoperative course were documented in 53
atients (51%): occurrence of postoperative heart failure in
9 (18%), neurologic deficit in 14 (13%), need for rethora-
otomy due to severe bleeding complications in 9 (9%),
ostoperative renal failure in 5 (5%), acute lung failure in 4
4%), and sepsis in 2 patients (2%), respectively. A compar-
son of demographic data and clinical characteristics of
atients is given in Table 2. Median NT-proBNP level
istribution of Patients by Different Chronic Health Conditionsnd In-Hospital Risk A sessment S ratified to Their Indiv dual Post
Table 2 Distribution of Patients by Different Chronic Health Coand In-Hospital Risk Assessment Stratified to Their Ind
No Event (
Demographics
Age, yrs, median (IQR) 56 (50–
Female, n (%) 26 (51)
Chronic health conditions and risk factors, n (%)
Extracardiac arteriopathy 3 (6)
Neurological dysfunction 1 (2)
Previous cardiac surgery 0 (0)
Serum creatinine 200 mmol/l 0 (0)
Pulmonary hypertension 0 (0)
Recent myocardial infarction 0 (0)
In-hospital assessment
Critical pre-operative state, n (%) 8 (16)
Left ventricular dysfunction, n (%) 4 (8)
Unstable angina, n (%) 0 (0)
NT-proBNP, median (IQR) (pg/ml) 227 (107
C-reactive protein, median (IQR) (mg/dl) 0.3 (0.0–
Total leukocyte count, median (IQR) (g/l) 9.7 (7.7–
EuroSCORE risk score, median (IQR)
Additional 7 (5–9
Logistic 10 (6–1
nless otherwise indicated, data are numbers (percentages). Classification of chronic health condit
f the following conditions: ventricular tachycardia or fibrillation or aborted sudden death, pre-op
notropic support, or pre-operative acute renal failure.
EuroSCORE  European System for Cardiac Operative Risk Evaluation; IQR  interquartile rangIQR) in 30-day survivors versus nonsurvivors was 328g/ml (157 to 569) versus 2,240 pg/ml (515 to 4,734; p 
.001), and in patients without versus with major adverse
vents 227 pg/ml (107 to 328) and 719 pg/ml (442 to 2,287;
 0.001), respectively (Fig. 1).
re-operative NT-proBNP and outcome prediction. We
pplied a multivariate model to assess the independent
ative Course
ns
al Post-Operative Course
) MAE/Death (n  53) p Value
62 (54–68) 0.19
13 (25) 0.016
2 (4) 0.68
2 (4) 1.00
4 (7) 0.12
9 (17) 0.0027
4 (7) 0.12
3 (6) 0.24
17 (32) 0.067
20 (38) 0.0004
3 (6) 0.24
719 (442–2,287) 0.0001
1.9 (0.0–9.3) 0.0029
13.9 (10.2–16.3) 0.013
9 (7–12) 0.0021
16 (9–32) 0.0021
d risk factors according to EuroSCORE criteria. Critical pre-operative state defined any one or more
cardiac massage, pre-operative ventilation before arrival in the anesthesia room, pre-operative
 major adverse event; NT-proBNP  N-terminal pro-brain natriuretic peptide.
Figure 1 Pre-Operative NT-proBNP as Outcome Predictor
in Surgery for Acute Type A Aortic Dissection
Pre-operative NT-proBNP in 104 patients undergoing emergency surgical repair
of type A aortic dissection with respect to post-operative occurrence of major
adverse events and 30-day mortality. Plots indicate median and interquartile
range (range from the 25th to the 75th percentile). Major adverse event was
defined as composite end point, including need for rethoracotomy, occurrence
of post-operative heart failure, neurologic deficit, lung failure, renal failure, or
sepsis. MAE  major adverse event; NT-proBNP  N-terminal pro-brain natri-
uretic peptide.-Oper
nditio
ividu
n  51
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March 18, 2008:1092–7 NT-proBNP and AADredictive value of pre-operative BNP-levels for outcome in
atients with acute aortic dissection adjusting for the logistic
uroSCORE and time of onset of symptoms: we grouped
aseline NT-proBNP levels in tertiles to obtain clinically
eaningful effect sizes for the risk of death and MAEs (Fig.
). Adjusted ORs for increasing tertiles of NT-proBNP
ompared with the lowest tertile were 0.98 (95% CI 0.18 to
.33; p  0.98) and 11.67 (95% CI 2.61 to 52.09; p 
.001) for 30-day mortality, and 9.07 (95% CI 2.58 to
1.83; p  0.001) and 50.21 (95% CI 10.85 to 232.45; p 
.001) for MAEs, respectively, indicating a significant
ssociation between pre-operative NT-proBNP levels and
utcome.
Comparable figures were obtained when adjusting for the
dditive EuroSCORE instead of the logistic EuroSCORE.
djusted ORs for increasing tertiles of NT-proBNP com-
ared with the lowest tertile were 1.03 (95% CI 0.19 to
.75; p  0.97) and 12.18 (95% CI 2.68 to 55.38; p 
Figure 2 Pre-Operative NT-proBNP Predicts 30-Day Post-Operat
After Adjustment for the Time Onset of Symptoms and
Adjusted odds ratios (OR) (diamonds) and 95% confidence intervals (CIs) (solid lin
(in tertiles) and occurrence of major adverse events or death within a 30-day post-
point, including need for rethoracotomy, occurrence of post-operative heart failure,
logistic EuroSCORE and time of onset of symptoms. EuroSCORE  European Syst
Figure 3 Pre-Operative NT-proBNP Predicts 30-Day Postoperati
Adjustment for the Time Onset of Symptoms and the
Adjusted ORs (diamonds) and 95% CIs (solid lines) comparing NT-proBNP levels o
30-day post-operative observation period. Major adverse event was defined as com
failure, neurologic deficit, lung failure, renal failure, or sepsis. Final models were a
left ventricular function,” “critical pre-operative state,” and “impaired renal functio.001) for 30-day mortality and 9.63 (95% CI 2.72 to 34.04;
 0.001) and 52.87 (95% CI 11.47 to 243.79; p  0.001)
or MAEs, respectively.
We further performed a second set of multivariable analysis,
djusting for potential confounders as indicated by univariate
nalyses instead of using only the logistic EuroSCORE and
he “time onset of symptoms.” By using univariate analysis,
e found that “gender,” “time onset of symptoms,” “pulmo-
ary hypertension,” “impaired left ventricular function,”
critical pre-operative state,” and “impaired renal function”
ere significant predictors of outcome. Adjusting for these
actors, risk estimates for tertiles of NT-proBNP were
ven greater than for the EuroSCORE-adjusted model,
ndicating that the latter one does not overestimate the
ffect (Fig. 3).
In final subgroup analysis, we further found NT-proBNP
evels 647 pg/ml to be significantly associated with occur-
ence of postoperative heart failure (adjusted OR [logistic]
utcome
Logistic EuroSCORE
mparing N-terminal pro-brain natriuretic peptide (NT-proBNP) levels on admission
ive observation period. Major adverse event was defined as composite end
logic deficit, lung failure, renal failure, or sepsis. Final models were adjusted for
Cardiac Operative Risk Evaluation.
tcome After
dual Patient’s Risk Profile
ission (in tertiles) and occurrence of major adverse events or death within a
end point, including need for rethoracotomy, occurrence of post-operative heart
d for “gender,” “time onset of symptoms,” “pulmonary hypertension,” “impaired
breviations as in Figure 2.ive O
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NT-proBNP and AAD March 18, 2008:1092–7.08 95% CI 2.06 to 40.07; p  0.004). For other MAEs,
owever, no significant correlation was observed.
iscussion
he present study demonstrates that pre-operative NT-
roBNP provides valuable information for risk stratification
f patients with acute type A aortic dissection. In this
atient population, concentrations of BNP 266 pg/ml
ere highly predictive for postoperative complications.
oreover, we found that a NT-proBNP level 647 pg/ml
n admission was a powerful predictive factor of 30-day
urvival.
So far, pre-operative NT-proBNP has not been evaluated
or its ability to predict postoperative complications after
mergency surgery for acute type A aortic dissection, nor has
T-proBNP ever been part of the standard pre-operative
ork-up. Furthermore, none of the risk assessment indices
ncorporate pre-operative BNP levels into their calculations
espite its proven correlation with outcome in both surgical
nd nonsurgical critically ill patients (4–12). In review of the
iterature, we have found one single study, reporting about
ncreased pre-operative levels in acute aortic disease (16).
Several studies have convincingly demonstrated that a
epsis-like state substantially contributes to morbidity and
ortality in acute aortic disease (17,18). Severe systemic
nflammatory response syndrome is further associated with
ardiovascular dysfunction. Cardiac dysfunction is a fre-
uent and important factor in determining outcome of
ritically ill patients associated with poor prognosis (13,14).
revious examinations demonstrated that increased plasma
evels of NT-proBNP are related to cardiovascular dysfunc-
ion in both surgical and nonsurgical critical ill patients
19–22). Thus, the levels of NT-proBNP observed in our
ohort may be attributed either to inflammation-induced,
ytokine-mediated NT-proBNP up-regulation, or to myo-
ardial dysfunction. Increased plasma levels of NT-proBNP
ay reflect not only the severity of myocardial depression
ut also the disease severity.
Another important finding of the present study is that
T-proBNP levels show a significant correlation with the
ime of onset of symptoms of acute aortic dissection. This
act again underlines the importance of early diagnosis and
ntervention in treatment of acute Stanford type A aortic
issection in improving survival (2).
Multiple factors have shown to contribute to outcomes
fter emergency surgery of acute aortic dissection (3,8–12);
hus, although a strong outcome predictor, pre-operative
T-proBNP may not be used as a “stand-alone” test in
linical routine but will substantially improve outcome
rediction in combination with existing risk indices. An
ntegrated approach would increase accuracy of pre-
perative risk assessment predicting morbidity and mortal-
ty. Risk stratification might allow identifying patients not
uitable for conventional surgical repair in circulatory arrest;
n those, endovascular treatment of type A dissection maye a new promising therapeutic option trying to reduce high
erioperative mortality in emergency surgery of acute aortic
issection (23,24).
tudy limitations. Some limitations of the present study
ave to be acknowledged. Although we could demonstrate
hat pre-operative NT-proBNP levels represent a powerful
redictor for outcome in patients undergoing surgical repair
f acute Stanford type A aortic dissection, sample size is
odest when it comes to random variability, resulting in
ide confidence intervals. From these data, a reliable cutoff
herefore cannot be derived and interrogation of larger
atabases will be necessary. Because of its low incidence—
revious studies suggest an incidence of 2.6 to 3.5 cases per
00,000 person-years (2,7)—our findings from a single-
enter study will ideally need confirmation in multicenter
tudies.
Although prospective, a remaining risk of selection bias
annot be excluded because only 88% of eligible patients
ould be included. However, considering overall death, our
ain end point, this bias appears to be negligible. Con-
ounding by patient-management at the emergency depart-
ent, operating theater, and intensive care unit, however,
ay be still present. Such confounders are impossible to
ontrol in an observational study.
Opposing these limitations, some arguments support our
ypothesis: first, we found an overall strong effect size both
or the primary and the secondary study end point; second,
here was a clear biological gradient; third, there is a
lausible pathophysiological background; and fourth, our
ndings are in line with similar investigations in the field.
onclusions
onsidering the variety of factors that might influence
ortality and morbidity following emergency surgery of
cute type A aortic dissection, pre-operative NT-proBNP-
easurement may represent a biomarker approach to esti-
ate outcome. Increased levels of NT-proBNP (647
g/ml in our observation) indicate unfavorable outcome.
uture studies should assess possible treatment strategies
elying on risk stratification derived from pre-operative
T-proBNP measurement.
eprint requests and correspondence to: Dr. Hans Domanovits,
epartment of Emergency Medicine, Vienna General Hospital,
edical School, Waehringer Guertel 18-20, A-1090 Vienna,
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